From Lesion to Double-Strand Break: The Replication Fork Collision | Visual AI Learning Guide

Watch the fork move toward the lesion. On the left, the crosslink is a covalent bridge between the two template strands. The helicase reaches it, cannot melt it, and the fork stalls. If the block is not removed, the fork collapses and the exposed template is cut — a double-strand break appears right at the fork. On the right, the lesion is a trapped topoisomerase complex. The fork collides with the trapped enzyme, the collision releases the enzyme and converts the reversible, protein-linked break into an irreversible double-strand break. Now compare with the cell that is not replicating. No fork ever arrives, so the lesion just sits there. The drug is in both cells, but only the replicating cell converts the lesion into the lethal break. That is the whole selectivity argument for this drug class.

0:00 / 0:00

Auto-play

A crosslink or a trapped cleavage complex is a problem, but it is not yet a double-strand break. The conversion happens when the replication machinery arrives.

During S phase, the replicative helicase unwinds the duplex ahead of the polymerase, and each strand is copied by a dedicated polymerase. An interstrand crosslink is a covalent bridge between the two templates. The helicase cannot melt it, and the polymerase cannot read through it, so the fork stalls. A stalled fork is not automatically fatal — the cell has fork-protection and repair pathways — but if the block is not removed, the fork can collapse. Collapse means the replication apparatus disassembles and the exposed single-stranded template is cleaved, producing a double-strand break at the fork. A single unrepaired interstrand crosslink is sufficient to kill a replicating cell, which is why these agents are so potent.

A topoisomerase cleavage complex produces the same outcome by a subtly different route. The trapped enzyme holds a nick or a double-strand cut with the enzyme still attached. When the replication fork reaches this complex, the advancing fork physically collides with the trapped enzyme. The collision converts the reversible, protein-linked break into an irreversible double-strand break, and it also releases the enzyme from the DNA. This is why topoisomerase poisons are far more toxic to dividing cells: the drug creates a latent lesion, and the fork collision is what detonates it.

The same logic explains the quiescent-cell tolerance. A cell in G0 is not replicating, so its forks never arrive at the lesion. The crosslink or the trapped complex persists, but without a fork collision it does not become a double-strand break. Transcription can also collide with these lesions and cause damage, but the dominant lethal event in proliferating cells is the replication fork collision. This is the phase-specific selectivity logic of this drug class: the drug is present in all cells, but only cells that replicate their DNA convert the lesion into the lethal double-strand break.